Troglitazone and small low-density lipoprotein in type 2 diabetes

被引：23

作者：

Hirano, T ^{[1
]}

Yoshino, G

Kazumi, T

机构：

[1] Showa Univ, Sch Med, Tokyo 142, Japan

[2] Toho Univ, Sch Med, Tokyo, Japan

[3] Ilyogo Rehabil Ctr Hosp, Tokyo, Japan

来源：

ANNALS OF INTERNAL MEDICINE | 1998年 / 129卷 / 02期

关键词：

D O I：

10.7326/0003-4819-129-2-199807150-00030

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：162 / 163

页数：2

共 5 条

[1] CHARACTERIZATION OF NEW ORAL ANTIDIABETIC AGENT CS-045 - STUDIES IN KK AND OB OB MICE AND ZUCKER FATTY RATS [J].

FUJIWARA, T ;

YOSHIOKA, S ;

YOSHIOKA, T ;

USHIYAMA, I ;

HORIKOSHI, H .

DIABETES, 1988, 37 (11) :1549-1558

[2] EFFECT OF NEW ORAL ANTIDIABETIC AGENT CS-045 ON GLUCOSE-TOLERANCE AND INSULIN-SECRETION IN PATIENTS WITH NIDDM [J].

IWAMOTO, Y ;

KUZUYA, T ;

MATSUDA, A ;

AWATA, T ;

KUMAKURA, S ;

INOOKA, G ;

SHIRAISHI, I .

DIABETES CARE, 1991, 14 (11) :1083-1086

[3]

KRAUSS RM, 1982, J LIPID RES, V23, P97

[4] INSULIN-RESISTANCE AND HYPERINSULINEMIA IN INDIVIDUALS WITH SMALL, DENSE, LOW-DENSITY-LIPOPROTEIN PARTICLES [J].

REAVEN, GM ;

CHEN, YDI ;

JEPPESEN, J ;

MAHEUX, P ;

KRAUSS, RM .

JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (01) :141-146

[5] LDL SUBCLASS PHENOTYPES AND THE INSULIN-RESISTANCE SYNDROME IN WOMEN [J].

SELBY, JV ;

AUSTIN, MA ;

NEWMAN, B ;

ZHANG, D ;

QUESENBERRY, CP ;

MAYER, EJ ;

KRAUSS, RM .

CIRCULATION, 1993, 88 (02) :381-387

← 1 →